Advanced Enzyme Technologies Announces AGM Date and Recommends Dividend for FY26
Advanced Enzyme Technologies Ltd has announced key dates for its 37th Annual General Meeting (AGM) and provided details regarding the final dividend recommended by the Board of Directors for the financial year 2025-26.The company confirmed that the 37th AGM is scheduled to be held on Friday, July 31, 2026. The meeting will be conducted through Video Conference or Other Audio Visual Means.
In addition to the AGM date, Advanced Enzyme Technologies set the Record Date for members regarding the recommended final dividend of ₹ 1.35/- per equity share. This dividend pertains to the financial year 2025-26 and is based on an equity share value of ₹ 2/- each. The Record Date has been fixed as Friday, July 24, 2026.
The record date is intended for ascertaining members' entitlement to this final dividend, pending its approval by the members at the AGM scheduled for July 31, 2026.
Should the dividend be approved or declared during the AGM, the company stated that the payment will be made on or after August 03, 2026, subject to deduction of tax at source.
The details regarding the security and relevant dates are provided below:
| Scrip Code | Symbol | Security Type | Record Date | Purpose |
|---|---|---|---|---|
| 540025 (BSE) | ADVENZYMES (NSE) | Equity shares | July 24, 2026 | For ascertaining the entitlement of Members for dividend if declared at 37th AGM on July 31, 2026 |
ADVENZYMES Stock Price Movement
Advanced Enzyme Technologies Limited shares closed today with a gain of 2.41%, settling higher after rising ₹7.55 per share in post-market trading. The equity saw robust activity, achieving an intraday high of ₹327.95 and recording a traded volume of 735,729 shares today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.